Goodness Growth Holdings & Green Goods® to Host Expungement Event at Baltimore Dispensary Psychedelics Investing
Nirvana Life Sciences Inc. Announces the Appointment of Jakson Inwentash to the Board of Directors Psychedelics Investing
COMPASS Pathways plc to announce first quarter 2022 financial results on 10 May 2022 Psychedelics Investing
COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression Psychedelics Investing
Vireo Health of Minnesota® and Green Goods® Launch the Green Ticket Giveaway Psychedelics Investing
Nirvana Life Sciences: Psychedelics for Opioid Addiction Recovery and Pain Management Psychedelics Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
